Crystal Adam

CIK 00018254452 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001825445

Recent Transactions

44 trades

Sale
Tango Therapeutics, Inc.$TNGX
Common Stock
2025-02-05$3.16/sh−6,851→ 158,210 total
Sale
Tango Therapeutics, Inc.$TNGX
Common Stock
2025-02-04$2.99/sh−7,432→ 165,061 total
Award
Tango Therapeutics, Inc.$TNGX
Stock Option (Right to Buy)
2025-02-03+318,090→ 318,090 total
Award
Tango Therapeutics, Inc.$TNGX
Common Stock
2025-02-03+53,015→ 172,493 total
Sale
Tango Therapeutics, Inc.$TNGX
Common Stock
2024-02-07$12.62/sh−4,083→ 119,478 total
Sale
Tango Therapeutics, Inc.$TNGX
Common Stock
2024-02-06$12.56/sh−4,288→ 123,561 total
Award
Tango Therapeutics, Inc.$TNGX
Common Stock
2024-02-01+46,599→ 46,599 total
Award
Tango Therapeutics, Inc.$TNGX
Stock Option (Right to Buy)
2024-02-01+279,593→ 279,593 total
Sale
Tango Therapeutics, Inc.$TNGX
Common Stock
2023-11-01$8.39/sh−7,507→ 81,250 total
Award
Tango Therapeutics, Inc.$TNGX
Common Stock
2023-03-01+81,250→ 81,250 total
Award
Tango Therapeutics, Inc.$TNGX
Stock Option (Right to Buy)
2023-03-01+487,500→ 487,500 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-01-30+3,750→ 21,398 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2023-01-30−3,750→ 18,750 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-01-30$7.78/sh−1,301→ 20,097 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-05-26$7.01/sh−1,102→ 17,648 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-05-25+3,750→ 18,750 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2022-05-25−3,750→ 22,500 total
Award
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2022-02-14+26,250→ 26,250 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2022-02-14+118,000→ 118,000 total
Sale
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-01-04$32.66/sh−1,054→ 15,000 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2022-01-04−15,000→ 112,292 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-01-04$6.49/sh+15,000→ 30,000 total
Sale
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-01-04$31.59/sh−13,946→ 16,054 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-12-22$6.49/sh+5,000→ 15,000 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2021-12-22−5,000→ 127,292 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-10-08$6.49/sh+10,000→ 10,000 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2021-10-08−10,000→ 132,292 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-10-01$4.98/sh+15,000→ 15,000 total
Sale
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-10-01$45.32/sh−8,176→ 5,112 total
Sale
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-10-01$45.99/sh−5,112→ 0 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2021-10-01−15,000→ 168,108 total
Sale
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-10-01$44.25/sh−1,712→ 13,288 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-07-29$4.98/sh+15,000→ 15,000 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2021-07-29−15,000→ 183,108 total
Sale
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-07-29$45.00/sh−15,000→ 0 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-07-01$6.50/sh+15,000→ 15,000 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2021-07-01−15,000→ 142,292 total
Sale
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-07-01$38.38/sh−1,700→ 0 total
Sale
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-07-01$37.93/sh−13,300→ 1,700 total
Sale
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-04-05$38.00/sh−10,879→ 0 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-04-05−15,000→ 157,292 total
Sale
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-04-05$37.16/sh−4,121→ 10,879 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-04-05$6.50/sh+15,000→ 15,000 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2021-02-11+87,850→ 87,850 total

Companies

Recent Filings

Address

C/O TANGO THERAPEUTICS, INC., 201 BROOKLINE AVE., SUITE 901

BOSTON, MA, 02215

View on SEC.gov